Advertisement winmatch

Final day to invest in Entero Healthcare IPO – should you subscribe or not?

The initial public offering (IPO) of products distributor firm Entero Healthcare Solutions opened on February 9 and will close on Tuesday. The 1600 crore IPO hoped to get by on day two with some positive response from retail investors, it was unsuccessful.

Competing with three other public offers, the IPO struggled to get through on the first day, competing with the other three IPOs. Not much enthusiasm was expressed by the retail investors, and there was very little response from non-institutional investors.

As per Mint, on the second day, the IPO’s subscription status was 19%: retail investors portion was subscribed 88%, Non-Institutional Investors (NII) portion was booked 9%, and Qualified Institutional Buyers (QIB) portion was yet to be booked. The employee portion, meanwhile, was subscribed 77%.

As per brokerage firm Swastika Investmart Limited, Entero Healthcare Limited has ‘lost money in the last three fiscal years.’
“This is due to negative cash flows from financing, investing, and operating activities. Additionally, the company’s operations demand a large amount of working capital. As it has been at a loss, we cannot define its P/E valuation. However, due to its current financial condition and other risk factors, we will avoid this IPO,” Shivani Nyati, Head of Wealth, Swastika Investmart, told Mint.

With the IPO closing today, potential investors are urged to consider the firm’s financial condition and assess the associated risk factors before deciding whether to subscribe or not. The future of Entero Healthcare Solutions remains uncertain based on its financial performance in recent years, and it’s advisable to approach this investment opportunity with caution.

Editorial Team

Passionate news enthusiast with a flair for words. Our Editorial Team author brings you the latest updates, in-depth analysis, and engaging stories. Stay informed with their well-researched articles.

Related Articles